A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients

被引：0
|
作者：
Gianluca Manni
Marco Centofanti
Mariacristina Parravano
Francesco Oddone
Massimo G. Bucci
机构：
[1] University of Rome Tor Vergata,Ophthalmology Department
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2004年 / 242卷
关键词：
Glaucoma; Timolol; Latanoprost; Ocular Hypertension; Bimatoprost;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：767 / 770
页数：3
相关论文
共 50 条
  • [41] Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
    Xinghuai Sun
    Ke Yao
    Qinghuai Liu
    Hong Zhang
    Xiaoli Xing
    Aiwu Fang
    Xuanchu Duan
    Minbin Yu
    Michelle Y. Chen
    Jingyuan Yang
    Margot L. Goodkin
    Ophthalmology and Therapy, 2023, 12 : 341 - 353
  • [42] Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
    Sun, Xinghuai
    Yao, Ke
    Liu, Qinghuai
    Zhang, Hong
    Xing, Xiaoli
    Fang, Aiwu
    Duan, Xuanchu
    Yu, Minbin
    Chen, Michelle Y.
    Yang, Jingyuan
    Goodkin, Margot L.
    OPHTHALMOLOGY AND THERAPY, 2023, 12 (01) : 341 - 353
  • [43] Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
    Masaru Inatani
    Yusuke Orii
    Kentaro Iwasaki
    Shogo Arimura
    Hiromi Sunagawa
    Minako Shiokawa
    Kenji Inoue
    Takuto Sakono
    Takato Sakono
    Rika Kuwamura
    Akiko Yoshida
    Junko Oi
    Yasuaki Kuwayama
    Kiyoshi Kano
    Noriaki Kido
    Akiko Matsuyama
    Mineo Ozaki
    Hideki Abe
    Chizuru Inoue
    Satoko Nakagawa
    Kunihiro Musashi
    Akiyasu Kanamori
    Jinhee Lee
    Shinichiro Otani
    Ryota Aoki
    Hirotaka Tanabe
    Shunsuke Nakakura
    Katsuyoshi Suzuki
    Takeshi Sagara
    Yoshiaki Saito
    Motoyasu Sameshima
    Mai Urahashi
    Fumika Watanabe-Kitamura
    Toshihiro Inoue
    Fumie Kagaya
    Yusuke Murai
    Sotaro Mori
    Kaori Ueda
    Takuji Kurimoto
    Yuko Yamada-Nakanishi
    Makoto Nakamura
    Takehiro Yamashita
    Sosuke Ishiyama
    Shinichi Manabe
    Keiko Takaki
    Ken Hayashi
    Akiko Ishida
    Aika Tsutsui
    Kaoru Manabe
    Masaki Tanito
    Advances in Therapy, 2023, 40 : 4074 - 4092
  • [44] Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
    Inatani, Masaru
    Orii, Yusuke
    Iwasaki, Kentaro
    Arimura, Shogo
    Sunagawa, Hiromi
    Shiokawa, Minako
    Inoue, Kenji
    Sakono, Takuto
    Sakono, Takato
    Kuwamura, Rika
    Yoshida, Akiko
    Oi, Junko
    Kuwayama, Yasuaki
    Kano, Kiyoshi
    Kido, Noriaki
    Matsuyama, Akiko
    Ozaki, Mineo
    Abe, Hideki
    Inoue, Chizuru
    Nakagawa, Satoko
    Musashi, Kunihiro
    Kanamori, Akiyasu
    Lee, Jinhee
    Otani, Shinichiro
    Aoki, Ryota
    Tanabe, Hirotaka
    Nakakura, Shunsuke
    Suzuki, Katsuyoshi
    Sagara, Takeshi
    Saito, Yoshiaki
    Sameshima, Motoyasu
    Urahashi, Mai
    Watanabe-Kitamura, Fumika
    Inoue, Toshihiro
    Kagaya, Fumie
    Murai, Yusuke
    Mori, Sotaro
    Ueda, Kaori
    Kurimoto, Takuji
    Yamada-Nakanishi, Yuko
    Nakamura, Makoto
    Yamashita, Takehiro
    Ishiyama, Sosuke
    Manabe, Shinichi
    Takaki, Keiko
    Hayashi, Ken
    Ishida, Akiko
    Tsutsui, Aika
    Manabe, Kaoru
    Tanito, Masaki
    ADVANCES IN THERAPY, 2023, 40 (09) : 4074 - 4092
  • [45] Clinical and microbiological effectiveness of photodynamic therapy on primary endodontic infections: a 6-month randomized clinical trial
    Rachel Garcia de Miranda
    Ana Paula Vieira Colombo
    Clinical Oral Investigations, 2018, 22 : 1751 - 1761
  • [46] Clinical and microbiological effectiveness of photodynamic therapy on primary endodontic infections: a 6-month randomized clinical trial
    de Miranda, Rachel Garcia
    Vieira Colombo, Ana Paula
    CLINICAL ORAL INVESTIGATIONS, 2018, 22 (04) : 1751 - 1761
  • [47] A double-masked, randomized, parallel comparison of a fixed combination of bimatoprost 0.03%/timolol 0.5% with non-fixed combination use in patients with glaucoma or ocular hypertension
    Robin, Alan L.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2007, 17 (04) : 685 - 686
  • [48] Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results From a Phase I/II Clinical Trial
    Lewis, Richard A.
    Christie, William C.
    Day, Douglas G.
    Craven, E. Randy
    Walters, Thomas
    Bejanian, Marina
    Lee, Susan S.
    Goodkin, Margot L.
    Zhang, Jane
    Whitcup, Scott M.
    Robinson, Michael R.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 175 : 137 - 147
  • [49] A double-masked, randomized, parallel comparison of a fixed combination of bimatoprost 0.03%/timolol 0.5% with non-fixed combination use in patients with glaucoma or ocular hypertension
    Hommer, A.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2007, 17 (01) : 53 - 62
  • [50] Bimatoprost 0.01% vs bimatoprost 0.03%: a 12-month prospective trial of clinical and in vivo confocal microscopy in glaucoma patients (vol 28, pg 422, 2014)
    Figus, M.
    Nardi, M.
    Piaggi, P.
    Sartini, M.
    Guidi, G.
    Martini, L.
    Lazzeri, S.
    EYE, 2014, 28 (04) : 506 - 506
12345